Deep Brain Stimulation Market Growth Report | Size & Share 2030

Deep Brain Stimulation Market Forecast to 2030 - Global Analysis by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson's Disease, Tremor, Dystonia, Epilepsy, Alzheimer's Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)

Publication Month : Aug 2023

  • Report Code : TIPHE100000996
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 168
Inquire Before Buy

PRICING

$4550

$3640

[Research Report] The deep brain stimulation market is expected to grow from US$ 603.52 million in 2022 and is expected to reach a value of US$ 1,155.37 million by 2030; it is anticipated to record a CAGR of 8.5% from 2022 to 2030. 

Market Insights and Analyst View:

A deep brain stimulator (DBS) is a brain stimulation device comprising a brain-oriented pacemaker (an implantable pulse generator) that sends electrical stimulation via surgically implanted electrodes to specific targets in the brain. DBS is generally used to treat movement disorders and neuropsychiatric disorders. The rising prevalence of neurological disorders and increasing demand for minimally invasive surgery are driving the deep brain stimulation market size. However, side effects associated with deep brain stimulation hinder the deep brain stimulation market growth. The rising prevalence of neurological disorders and increasing demand for minimally invasive surgery are expected to propel the deep brain stimulation market growth during the forecast period.

Growth Drivers and Challenges:

The geriatric population is susceptible to neurological diseases. Neuropathy, Parkinson's disease, Alzheimer's disease, and dystonia are among the most common neurological disorders affecting older people. According to the National Institutes of Health (NIH), 8.5% of the world's population (i.e., ~617 million people) are 65 and above. The prevalence of movement disorders and psychiatric disorders is high among the geriatric populations in countries such as the US and Canada. According to the World Health Organization (WHO), neurological diseases contribute 6.3% to the global disease burden and are one of the leading causes of death across the world. In addition, 13.2% of deaths in developed countries and 16.8% of deaths in low- and middle-income countries are reported due to neurological diseases.

Deep brain stimulation is a minimally invasive targeted surgery used to treat movement disorders in dystonia, Parkinson's disease, and essential tremor. Minimally invasive surgeries (MIS) offer several advantages over traditional surgical techniques. MIS minimizes trauma to the body, reduces postoperative pain, increases recovery speed, and improves outcomes. Also, these procedures require tiny incisions large enough to insert thin tubes and cameras. These benefits of MIS are increasing inpatients and have encouraged older patients who face high operative morbidity and mortality to seek surgery. Therefore, growing awareness regarding the burden of neurological disorders, the rising geriatric population, the increasing prevalence of neurological diseases, and the rising demand for minimally invasive surgeries due to their advantages propel the demand for deep brain stimulators as a therapy.

Deep brain stimulation (DBS) effectively treats multiple neurological and psychiatric indications; however, surgical and hardware-related adverse events (AEs) can negatively impact the quality of life. Patients may experience side effects depending on their medication and initial programming in the initial weeks and months after a DBS procedure. Patients often experience discomfort related to the device's neurostimulator (or battery pack) implanted under the skin near the collarbone. The side effects were significantly more common in patients who underwent bilateral DBS than in patients who underwent unilateral DBS. There are various risks associated with deep brain stimulation procedures, such as lead misplacement and bleeding in the brain. The implanted pulse generator (IPG) is a basic energy source and a configurable component of DBS devices. The risk of infection from IPG limits the use of deep brain stimulation devices for Parkinson's disease. Therefore, the side effects of deep brain stimulation hinder the deep brain stimulation market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Deep Brain Stimulation Market: Strategic Insights

deep-brain-stimulation-market
Market Size Value inUS$ 603.52 million in 2022
Market Size Value byUS$ 1,155.37 million by 2030
Growth rateCAGR of 8.5% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The global deep brain stimulation market is segmented on the basis of product, application, end user, and geography. Based on product, the deep brain stimulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and systems. Based on application, the deep brain stimulation market is segmented into Parkinson's disease, tremor, Alzheimer’s disease, dystonia, epilepsy, and others. Based on end user, the deep brain stimulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. The deep brain stimulation market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

Based on product, the deep brain stimulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and systems. The dual channel deep brain stimulator segment held the largest market share in 2022; moreover, the same segment is anticipated to register the highest CAGR of 9.5% during the forecast period. Dual channel DBS offers the best overall support as well as efficiently reduces patient tremors. The Kinetra internal pulse generator (IPG) by Medtronic was the first dual-channel IPG, which became available in 1998. The growing adoption of dual channel DBS for the treatment of various neurological disorders, such as dystonia, Parkinson’s disease, Alzheimer’s disease, and epilepsy, is a key factor fueling the segment growth. Moreover, product approvals are propelling the growth of the dual channel stimulators segment. For instance, in January 2020, Abbott’s Infinity DBS system received FDA approval for the treatment of Parkinson's disease. This system specifically targets the brain called internal globus pallidus (GPi), which is associated with Parkinson's disease symptoms. In addition, Vercise, Vercise PC, & Vercise Gevia DBS systems by Boston Scientific; Activa PC & Activa RC by Medtronic; and Infinity by Abbott are a few of the key offerings in the segment. Thus, the advantages of dual channel stimulation, along with product approvals, are expected to boost the dual channel deep brain stimulator segment growth during the forecast period.

Deep Brain Stimulation Market, by Product – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Based on application, the deep brain stimulation market is segmented into Parkinson's disease, tremor, Alzheimer’s disease, dystonia, epilepsy, and others. The Parkinson's disease segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR of 8.5% during the forecast period. Parkinson's disease (PD) is a neurological disorder that causes difficulty in walking, coordinating, and balancing, as well as shaking and stiffness. A few factors such as the rising number of deep brain stimulation therapies that the US Food and Drug Administration (FDA) has approved, the surge in patients suffering from PD worldwide, and the growing approval for DBS products are expected to support the segment growth in the coming years. For instance, according to the Parkinson’s Foundation estimates, ~60,000 Americans are diagnosed with PD yearly. In addition, 1 million people in the US are suffering from PD, and the number is expected to reach 1.2 million by 2030. There are various innovative product launches across the globe. For instance, in January 2021, Medtronic launched the First-of-its kind Adaptive deep brain stimulation (aDBS) trial for evaluating the safety and efficacy of adaptive deep brain stimulation in PD patients. Hence, the above-mentioned factors significantly augment the segment growth in deep brain stimulation market growth during the forecast period.

Based on end user, the deep brain stimulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR of 9.1% during the forecast period. The hospitals segment is expected to grow significantly owing to the rising prevalence of various neurological conditions such as Parkinson's and Alzheimer's disease and other disorders that can be treated effectively by skilled professionals in hospital settings. There is an increase in the number of deep brain stimulation (DBS) surgeries performed in hospitals and the presence of state-of-the-art facilities across hospital settings. As per a study titled “Single-Stage Deep Brain Stimulator Placement for Movement Disorders,” published in 2021—approximately 160,000 patients worldwide have undergone DBS for various neurological and non-neurological conditions, and ~12,000 new patients receive DBS annually. In addition, hospitals also employ the highest quality of professional staff, including skilled and experienced neurologists, nurses, and technicians, that work together to provide patients with the best surgical care in a pleasant environment. Hence, the availability of technologically advanced DBS devices, along with favorable reimbursement policies, is expected to propel the hospital segment during the forecast period.

Regional Analysis:

Based on geography, the deep brain stimulation market is divided into five key regions—North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North America accounted for the largest share of the global deep brain stimulation market in 2022. The North America deep brain stimulation market is segmented into the US, Canada, and Mexico. The US held the largest deep brain stimulation market share and is anticipated to register the highest CAGR during the forecast period. The market growth is attributed to the rising prevalence of neurological diseases such as Parkinson's disease (PD), rising awareness about neurological disorders, and growing investments in developing transcranial stimulators. According to a study titled “2022 Alzheimer's disease facts and figures” published in the Alzheimer's Association, ~6.5 million Americans aged 65 and above suffered from Alzheimer's disease in 2022, and the number is projected to rise to 13.8 million by 2060. In addition, according to the Parkinson's Foundation, ~1 million people in the US are suffering from Parkinson's disease, which is expected to reach 1.2 million by 2030.

Europe recorded the second-largest market for deep brain stimulation. The Europe deep brain simulation market is witnessing rapid growth due to a rise in innovative product launches by key regional deep brain stimulation companies. In June 2020, Medtronic announced the launch of the PerceptTM PC Neurostimulator with BrainsenseTM technology. The technology simultaneously records and delivers electrical stimulations to the brain to relieve symptoms of Parkinson's disease (PD). Germany and the UK are expected to witness growth in the DBS market in the region. The Asia Pacific deep brain stimulation market is expected to register the highest CAGR during the forecast period. Increasing innovative technology trends in the DBS field and rapid adoption of artificial intelligence (AI) and machine learning (ML) are key factors driving the growth of the market in the region. In February 2023, the China National Medical Products Administration approved NERVTEX, which specializes in developing digital treatments for brain diseases, such as AI-powered software for analyzing movement disorders. Also, Movement Dysfunction Assessment Software (MoDAS) is a medical device to analyze a patient's movement activity recorded with mobile phones. Factual and numeric data is then provided to diagnose and manage the patient's movement.

COVID-19 Impact:

Brain surgeries were postponed or even canceled to reduce the transmission of COVID-19. According to the Prime Minister’s Decree of March 2020, the containment measures in Italy led to a reduction in routine hospital activities. In the worst-affected nations, such as the US, India, Brazil, France, the UK, Italy, and Spain, neurosurgical operations fell by 55%. The COVID-19 pandemic negatively impacted the deep brain stimulation market. In December 2020, according to the report of the National Center of Biotechnology Information, lockdown restriction measures confined people to their homes and recorded subjective worsening of motor and psychiatric symptoms, such as sleeping problems in patients suffering from Parkinson’s Disease and dystonic patients and being treated with DBS. The restrictions led to an increased burden of neurological disease and chronic stress related to DBS management. With the ease of lockdown restrictions, healthcare professionals recommenced the resumption of brain surgeries. Globally increased activities in tele-consultancy for follow-up and routine check-ups to address the symptoms of PD patients in the post-pandemic period are playing a key role in increasing the demand for treatment options such as deep brain stimulation. Thus, such trends are expected to impact the adoption of DBS in the coming years and continue to grow significantly during the forecast period.  

Competitive Landscape and Key Companies:

A few of the prominent players operating in the global deep brain stimulation market include Abbott Laboratories, Aleva Neurotherapeutics SA, Medtronic Plc, Beijing PINS Medical Co Ltd, Boston Scientific Corp, Newronika SpA, and SceneRay Co Ltd. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their deep brain stimulation market share.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Application, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What was the estimated deep brain stimulation market size in 2022?

The deep brain stimulation market was valued at US$ 603.52 million in 2022.

What are the growth estimates for the deep brain stimulation market till 2030?

The deep brain stimulation market is expected to be valued at US$ 1,155.37 million by 2030.

Who are the major players in the deep brain stimulation market?

The deep brain stimulation market majorly consists of the players, including Abbott Laboratories, Aleva Neurotherapeutics SA, Medtronic Plc, Beijing PINS Medical Co Ltd, Boston Scientific Corp, Newronika SpA, and SceneRay Co Ltd.

Which segment is dominating the deep brain stimulation market?

The deep brain stimulation market, based on product, is segmented into single-channel deep brain stimulators, dual-channel deep brain stimulators, and software and accessories. The dual-channel deep brain stimulators segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period.

What is meant by the deep brain stimulation?

A deep brain stimulator (DBS) is a device comprising a brain-oriented pacemaker that sends electrical stimulation through surgically-implanted electrodes to specific targets in the brain. DBSs are commonly used to treat movement disorders as well as neuropsychiatric disorders.

What are the driving factors for the deep brain stimulation market?

The factors driving the growth of the deep brain stimulation market include the rising prevalence of neurological disorders and increasing demand for minimally invasive surgery. However, the side effects associated with deep brain stimulation hamper the growth of the deep brain stimulation market.

The List of Companies - Deep Brain Stimulation Market

  1. Abbott Laboratories
  2. Aleva Neurotherapeutics SA
  3. Medtronic Plc
  4. Beijing PINS Medical Co Ltd
  5. Boston Scientific Corp
  6. Newronika SpA
  7. SceneRay Co Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Deep Brain Stimulation Market